For example, the 2017 AAP guideline indicates that it would be reasonable to use aldosterone receptor antagonists (such as spironolactone) to treat resistant hypertension among children in a similar manner as in adults,45 and existing literature highlights the frequent combination of spironolactone with oral contraceptive pills to treat adolescent PCOS.27 This evidence concerns the gene NR3C2 and hypertensive disorder.